Go back
HSA-MIR-1290
| Id | 330 |
| Name | hsa-mir-1290 |
| Chromosome | chr1 (NC_000001) |
| PrecStart | 18897071 |
| PrecEnd | 18897148 |
| Length | 78 |
| Strand | reverse |
| Is at most 5 Mbp to chromosome end | Yes |
| Is at most 5 Mbp to chromosome centromere | Yes |
| Protein host gene | ALDH4A1 |
| Intronic | Yes |
| Clustered | No |
| Probability | 0.5865625852627285 |
| ChrEnd | 1 |
| ChrCentr | 1 |
DOI | Detected in | In presence of | Expression profile |
|---|---|---|---|
| https://doi.org/10.3233/cbm-170029 | Xie Rui, Wu Shang-Nong, Gao Cheng-Cheng, Yang Xiao-Zhong, Wang Hong-Gang, Zhang Jia-Ling, Yan Wei, Ma Tian-Heng (2017). Prognostic value of combined and individual expression of microRNA-1290 and its target gene nuclear factor I/X in human esophageal squamous cell carcinoma. Cancer Biomarkers, 20(3), 325-331. | esophageal squamous cell carcinoma | up |
| https://doi.org/10.1016/j.biopha.2015.10.005 | Mao Yu, Liu Jia, Zhang Dakai, Li Baosheng (2015). RETRACTED: MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). Biomedicine & Pharmacotherapy, 76(), 82-93. | esophageal squamous cell carcinoma | up |
| https://doi.org/10.3748/wjg.v21.i11.3245 | Li Ming, He Xiao-Yan, Zhang Zhi-Mei, Li Shuo, Ren Li-Hua, Cao Ri-Sheng, Feng Ya-Dong, Ji Yin-Lin, Zhao Ye, Shi Rui-Hua (2015). MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis. World Journal of Gastroenterology, 21(11), 3245-3255. | esophageal squamous cell carcinoma | up |
| https://doi.org/10.18632/oncotarget.24046 | Xiao Xuelian, Yang Daheng, Gong Xue, Mo Dongping, Pan Shiyang, Xu Jian (2018). miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4. Oncotarget, 9(15), 11977-11988. | lung adenocarcinoma | up |
| https://doi.org/10.1016/j.lungcan.2015.11.013 | Kim Gwangil, An Hee-Jung, Lee Mi-Jung, Song Ji-Ye, Jeong Ju-Yeon, Lee Ji-Hyun, Jeong Hye-Cheol (2016). Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. Lung Cancer, 91(), 15-22. | non-small cell lung cancer | up |
| https://doi.org/10.1177/1533033820973276 | Liu Jinghao, Han Yueting, Liu Xingyu, Wei Sen (2020). Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment, 19(), 153303382097327. | non-small cell lung cancer | up |
| https://doi.org/10.18632/oncotarget.14930 | Yoshino Hirofumi, Yonemori Masaya, Miyamoto Kazutaka, Tatarano Syuichi, Kofuji Satoshi, Nohata Nijiro, Nakagawa Masayuki, Enokida Hideki (2017). microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma. Oncotarget, 8(13), 20881-20894. | renal clear cell carcinoma | up |
| https://doi.org/10.1016/j.canlet.2012.10.038 | Wu Jia, Ji Xiaowei, Zhu Linlin, Jiang Qiaoli, Wen Zhenzhen, Xu Song, Shao Wei, Cai Jianting, Du Qin, Zhu Yongliang, Mao Jianshan (2013). Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Cancer Letters, 329(2), 155-163. | colon cancer | up |
| https://doi.org/10.3233/cbm-170029 | Xie Rui, Wu Shang-Nong, Gao Cheng-Cheng, Yang Xiao-Zhong, Wang Hong-Gang, Zhang Jia-Ling, Yan Wei, Ma Tian-Heng (2017). Prognostic value of combined and individual expression of microRNA-1290 and its target gene nuclear factor I/X in human esophageal squamous cell carcinoma. Cancer Biomarkers, 20(3), 325-331. | esophageal squamous cell carciFalsema | up |
| https://doi.org/10.1016/j.biopha.2015.10.005 | Mao Yu, Liu Jia, Zhang Dakai, Li Baosheng (2015). RETRACTED: MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). Biomedicine & Pharmacotherapy, 76(), 82-93. | esophageal squamous cell carciFalsema | up |